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Summary
Objective: We previously reported that nonsteroidal anti-inﬂammatory drugs (NSAIDs) aggravated cartilage degeneration and that hyaluronate
(HA) reversed the cartilage destruction accelerated by NSAIDs in a rabbit osteoarthritis (OA) model. In the present study, we analyzed the
mechanisms of these effects of NSAIDs and HA.
Method: An experimental rabbit model of OA was induced by partial meniscectomy and treated with NSAIDs, HA and the combination of
NSAIDs and HA over 2 weeks. After sacriﬁce, cartilage degeneration and the levels of matrix metalloproteases (MMP)-1, MMP-3 and
MMP-13 in synovial lavage ﬂuid were measured. In an in vitro study, human articular chondrocytes were cultured with NSAIDs and HA in
the presence of interleukin (IL)-1b or IL-6þ sIL-6 for 24 h. After culture, the production of MMPs, IL-1b, and IL-6 was measured.
Results: The levels of MMP-1, MMP-3 and MMP-13 in synovial ﬂuid from the NSAID-treated group were signiﬁcantly higher than in controls.
The increased production of MMPs induced by NSAIDs was counteracted by the concomitant administration of HA. In vitro studies showed
that NSAIDs augmented IL-1b- and IL-6-induced production of MMPs from human chondrocytes, while completely inhibiting the IL-1b- and
IL-6/sIL-6R-induced production of prostaglandin E2 (PGE2). The addition of PGE2 did not reduce the augmentation of MMP production. HA
inhibited the promotion of cytokine-induced MMP and cytokine production by NSAIDs.
Conclusions: Our data clearly showed that HA inhibited NSAID-accelerated MMP production which was followed by inﬂammatory cytokine
production from cytokine-activated chondrocytes. The results warrant further evaluation of the potential chondroprotective effects of co-admin-
istration of HA with NSAIDs.
ª 2009 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
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Inﬂammatory cytokines such as interleukin (IL)-1 and IL-6
play a crucial role in the process of cartilage degradation
in osteoarthritis (OA). These cytokines induce the produc-
tion of matrix metalloproteases (MMPs) and decrease the
synthesis of tissue-speciﬁc macromolecules including type
II collagen and aggrecan1. IL-1b and IL-6 are abundantly
synthesized by OA synovium and increased levels of these
cytokines are observed in OA synovial ﬂuid and serum2.
From these lines of evidence, it is very likely that elevated
MMPs and decreased extracellular matrix synthesis in-
duced by inﬂammatory cytokines results in degradation of
articular cartilage in OA patients.
Intra-articular injection of high molecular weight sodium
hyaluronate (HA) is now widely used in the treatment of
OA. The main mechanism by which HA prevents cartilage
destruction and slows OA disease progression is considered
to be its action in maintaining the viscoelastic properties of
synovial ﬂuid, because this is reduced by inﬂammation in
OA patients3. However it is reported that HA itself sup-
presses the induction of inﬂammatory cytokines, MMPs*Address correspondence and reprint requests to: Masahiko
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1513and cycloxygenase-2/prostaglandin E2 (PGE2) in synovium
and chondrocytes4e7.
We previously reported a beneﬁt of the concomitant use
of nonsteroidal anti-inﬂammatory drugs (NSAIDs) and HA
using a rabbit OA model8. NSAIDs are widely used to re-
lieve pain in OA patients. Indeed, our previous data demon-
strated that the pain which increased with the progression of
cartilage destruction was alleviated by treatment with
NSAIDs. To our surprise, however, NSAID monotherapy
aggravated cartilage degeneration. In contrast, HA mono-
therapy or the concomitant use of HA together with NSAIDs
protected the cartilage. The precise mechanisms by which
NSAIDs promote cartilage destruction and HA blocks this
destruction are not well-understood, however.
In the present study, we found that NSAID treatment aug-
mented MMP production and the combination therapy of
NSAID and HA reduced MMP production in synovial lavage
ﬂuid in the rabbit OA model. Therefore, we then studied the
effects of NSAIDs and HA on the production of MMPs
and inﬂammatory cytokines using human articular
chondrocytes.
Materials and methodsREAGENTSRecombinant human IL-6, soluble IL-6 receptor (sIL-6R) and humanized
anti-human IL-6R antibody (tocilizumab) were prepared in our laboratories.
Recombinant human IL-1b and IL-1R antagonist were purchased from
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1514 M. Hashizume and M. Mihara: Effect of HA and NSAID on MMP productionR&D Systems (Minneapolis, MN, USA). Loxoprofen monosodium was pur-
chased from CHEMIX Inc. (Yokohama, Kanagawa, Japan). Indomethacin
(IND), dexamethasone (DEX) and PGE2 were purchased from Wako
(Osaka, Japan), and celecoxib (CLE) was purchased from Kemprotec (Mid-
dlesbrough, UK). High molecular weight HA (Suvenyl) was obtained from
Chugai Pharmaceutical Co., Ltd. (Tokyo, Japan). Its average molecular
weight is 2700 kDa (viscosity average molecular weight is 1900 kDa). It
was produced by fermentation method using Streptococcus equi and pre-
pared as formulation at the concentration of 10 mg/mL.MEXPERIMENTAL OA MODEL IN RABBITS250
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† †We developed the experimental rabbit OA model as previously de-
scribed8. Brieﬂy, left knee joints of male 13-week-old Kbl:JW rabbits
(Kitayama Labes, Ina, Nagano, Japan) were incised aseptically about 2 cm
down the lateral aspect of the patella to expose and cut the lateral collateral
ligament. The end of the popliteus muscle tendon was incised to expose the
lateral meniscus, which was then resected in the midsection for 3e4 mm.
The subdermal muscular layer and skin were sewed by knotted sutures.
This partial meniscectomy was conducted just before administration of the
test drugs.
The rabbits were divided into four groups, with eight animals in each group.
The control group was administered water orally and saline intra-articularly.
The NSAIDs group was administered loxoprofen orally and saline
intra-articularly. The HA group was administered water orally, and HA intra-
articularly. The NSAIDsþHA group was administered loxoprofen orally, and
HA intra-articularly. After receiving these treatments for 2 weeks, the animals
were sacriﬁced.200
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† †Immediately after sacriﬁce, the knee joint cavity was washed with 2 mL of
saline, synovial lavage ﬂuid was collected and the concentrations of MMP-1,
MMP-3, and MMP-13 therein were evaluated by enzyme-linked
immunoassay (ELISA). Human Biotrak MMP-1 and MMP-13 ELISA kits
(RPN2610, RP2621; GE Healthcare, Buckinghamshire, UK) and MMP-3
(R&D) were used, because these ELISA kits were previously shown to be
suitable for assaying rabbit MMPs9.control NSAID HA NSAID+HACULTURE OF HUMAN CHONDROCYTES
Fig. 1. MMP levels in synovial lavage ﬂuid from a rabbit OA
model. OA-model rabbits were administered loxoprofen orally,
with and without intra-articular injection of HA. Synovial lavage ﬂuid
was collected as described in Materials and methods. MMPs were
measured by ELISA. Columns and error bars indicate the mean
and SE of eight animals. Statistical signiﬁcance was analyzed by
the unpaired test and Dunnett’s test (*P< 0.05 vs control group,
yP< 0.05 vs NSAID group).Human chondrocytes were purchased from Cell Applications (San Diego,
CA, USA). We used cells from passages 4 to 8. Chondrocytes (2 105 cells/
1 mL/well) were cultured in a 12-well plate using chondrocyte growth medium
(Cell Applications) for 24 h. After conﬂuence, the cells were stimulated with
IL-1b (5 ng/mL) or IL-6 (100 ng/mL)þ sIL-6R (100 ng/mL) for 24 h in the
presence or absence of anti-inﬂammatory drugs (CLE, IND or DEX) with
or without HA, PGE2, anti-IL-6 receptor antibody (tocilizumab) or IL-1 recep-
tor antagonist. Culture supernatants were then collected. MMP-1, -3 and -13
(all from R&D), IL-1b and IL-6 (GE Healthcare) and PGE2 (Neogen, Lexing-
ton, KY, USA) concentrations in the supernatants were measured using each
ELISA kit according to the manufacturer’s instructions. All cultures were per-
formed in triplicate.STATISTICAL ANALYSISStatistical signiﬁcances were analyzed by the unpaired t-test and Dun-
nett’s test using a software package (Statistical Analysis System: SAS
Institute Japan, Tokyo, Japan) with the signiﬁcance level set to 5%.
ResultsLEVELS OF MMPs IN SYNOVIAL FLUIDS IN THE RABBIT OA
MODELPreviously we reported that the damaged area of carti-
lage in this rabbit model was worsened by NSAID mono-
therapy and that NSAID-accelerated cartilage destruction
was suppressed by the concomitant administration of
HA8. In order to analyze the mechanism whereby NSAIDs
increased cartilage destruction, we measured the levels of
MMP-1, MMP-3 and MMP-13 in synovial lavage ﬂuids
(Fig. 1). The levels of all three were found to be higher in
the NSAID-treated group than in the control group. In con-
trast, the HA and NSAIDþHA groups had lower levels of
MMPs than the NSAIDs group.NSAIDs AUGMENTED MMPs PRODUCTION BY CYTOKINESTo examine the direct effect of NSAIDs on MMP production
in chondrocytes, drugs such as CLE and IND, and DEX,
were added to human chondrocytes in the presence of IL-1b
(5 ng/mL) or IL-6 (100 ng/mL)þ sIL-6R (100 ng/mL). Morpho-
logical change of cells was not observed. As shown in
Table I, NSAIDs signiﬁcantly enhanced MMP-1, MMP-3 and
MMP-13 production induced by IL-1b or IL-6þ sIL-6R, and
this was not affected by DEX. However, PGE2 production by
IL-1b and IL-6þ sIL-6R was inhibited by all three drugs.
Next, we examined whether the addition of PGE2 reduced
MMP production induced by NSAIDs. PGE2 (10 ng/mL) was
added to the medium in the presence of NSAIDs and IL-1b or
IL-6þ sIL-6R. However, PGE2 did not affect the production
of MMP-1, -3 or -13 augmented by NSAIDs.NSAIDs INDUCE CYTOKINE PRODUCTIONWemeasured IL-1b and IL-6 production in supernatants be-
cause these factors are potent inducers of MMPs. CLE and
INDpotentlyaugmented IL-1b-induced IL-1band IL-6-induced
IL-6 production, whereas DEX did not affect (Fig. 2). CLE and
Table I
Effects of NSAIDs on cytokine-induced MMP and PGE2 production by chondrocytes
MMP-1 (ng/mL) MMP-3 (ng/mL) MMP-13 (pg/mL) PGE2 (ng/mL)
None 2.7 0.0 3.6 0.0 12.3 0.0 23.0 0.4
IL-1b 13.1 0.4 40.0 1.2 131.2 0.4 43.4 2.4
IL-1bþCLE 24.5 0.0* 143.5 14.7* 186.2 0.2* 21.0 1.6*
IL-1bþ IND 26.5 0.0* 74.9 2.7* 165.8 0.0* 19.2 1.2*
IL-1bþDEX 13.0 0.0 8.8 0.4 83.7 0.1 23.3 0.9*
IL-6þ sIL-6R 14.0 0.4 39.8 1.5 70.1 0.4 44.2 0.9
IL-6þ sIL-6RþCLE 28.9 0.5* 80.5 2.9* 144.4 0.5* 25.2 1.3*
IL-6þ sIL-6Rþ IND 32.2 0.5* 139.5 2.9* 160.8 0.5* 23.7 0.3*
IL-6þ sIL-6RþDEX 9.8 0.0 7.5 0.8 36.6 0.1 23.0 0.7*
Human chondrocytes were cultured with CLE (1000 nM), IND (100 nM) or DEX (100 nM) in the presence of IL-1b (5 ng/mL) or IL-6/sIL-6R
(both 100 ng/mL) for 24 h. After culture, the concentrations of MMPs and PGE2 in the supernatant were determined by ELISA. Each value
indicates the mean and SD of triplicate culture. Statistical signiﬁcance was analyzed by Dunnett’s test (*P< 0.05 vs IL-1b or IL-6/sIL-6R).
1515Osteoarthritis and Cartilage Vol. 17, No. 11IND augmented IL-1b and IL-6 mRNA expression induced by
IL-1b and IL-6 respectively. In contrast, DEX reduced the
mRNA level of IL-1b-induced IL-1 and IL-6-induced IL-6 com-
pared to the control group (data not shown).HA REDUCED CYTOKINE-INDUCED MMP PRODUCTIONWe examined the inﬂuence of HA on cytokine-induced
MMP production by chondrocytes. Both HA and anti-IL-6R
antibody were found to inhibit the induction of MMP produc-
tion by IL-6þ sIL-6R [Fig. 3(A)]. Similarly, the induction of
MMP production by IL-1b was inhibited by the addition of
either HA and an IL-1R antagonist [Fig. 3(B)].HA REDUCED NSAID-AUGMENTED MMP PRODUCTIONNext, we examined the effect of HA on NSAID-acceler-
ated MMP production. Cells were stimulated with IL-1b or
IL-6þ sIL-6R in the presence of NSAIDs with or without
HA (1 mg/mL) for 24 h and then the levels of MMPs were
measured. Cytokine-induced MMP production was aug-
mented by NSAIDs and NSAID-augmented MMP produc-
tion was signiﬁcantly suppressed by the addition of HA
(Figs. 4 and 5). HA also signiﬁcantly suppressed the
NSAID-augmented production of IL-1b and IL-6.Discussion
Intra-articular injection of HA is widely used to treat the pa-
tientswithmoderate to severeOA.HAhasbeendemonstrated
topotently inhibit inﬂammatory cytokines,MMPs,proteoglycanIL-1β
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Fig. 2. NSAIDs augmented cytokine-induced production of IL-1b and
6/sIL-6R in the presence of an NSAID (CLE or IND) or DEX. After culture,
by ELISA. ‘‘None’’ indicates nothing was added, ‘‘Control’’ indicates that o
the mean and SD of triplicate cultures. Statistical signiﬁcanceandPGE2 insynoviumandchondrocytes
10e13andmaymodify
the structural changeof diseased joints and slow the rateofOA
diseaseprogression.However, since theonset of analgesicef-
fect of HA is slow, the combination use with HA and NSAIDs is
recommended for pain management.
The efﬁcacy of NSAIDs for pain relief is well recognized,
but it remains controversial whether these agents can ame-
liorate cartilage destruction in OA. There are reports that
NSAIDs increased the synthesis of proteoglycans and HA
in OA cartilage14e16. However, some reports showed that
NSAIDs in clinical use actually accelerated the progression
of OA17,18. Previously, we reported that NSAID treatment
caused visible damage and resulted in poorer histopatho-
logical scores for cartilage degeneration in the rabbit OA
model8. However, the precise mechanisms responsible for
this phenomenon are not well-understood.
To approach this problem, ﬁrst we measured the levels of
MMPs in synovial lavage ﬂuid in the rabbit OAmodel in which
NSAID treatment accelerated cartilage destruction. We found
that in theNSAIDs group, the levels ofMMPswere higher than
in control group, but that this augmentation of MMPswas sup-
pressed in the group co-administeredNSAIDs andHA.MMPs
are theproteases that participate in irreparableproteolyticdeg-
radation and remodeling of the extracellular matrix. In fact, it is
reported that their levels are clearly elevated in OA and rheu-
matoid arthritis (RA) patients19,20. These facts suggest that el-
evated MMP production might be a cause of the accelerated
cartilage destruction observed with NSAID treatment.
Next, we investigated the effects of NSAIDs and HA admin-
istration in an in vitro model using cultured human chondro-
cytes. Although NSAIDs did not directly induce MMP
production from chondrocytes, they augmented their200
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Fig. 3. HA inhibited the IL-6/sIL-6R- and IL-1b-induced production of MMP. Human chondrocytes were stimulated for 24 h (A) with IL-6/
sIL-6R in the presence of anti-IL-6 receptor antibody (tocilizumab, 100 mg/mL) or HA (0.01, 0.1, 1 mg/mL) and (B) with IL-1b in the presence of
an IL-1 receptor antagonist (IL-1Ra, 50 mg/mL) or HA (1 mg/mL). ‘‘None’’, ‘‘Control’’, columns and error bars as in Fig. 2. Statistical signiﬁcance
was analyzed by Dunnett’s test (*P< 0.05 vs none, yP< 0.05 vs control).
1516 M. Hashizume and M. Mihara: Effect of HA and NSAID on MMP productioncytokine-induced production. Furthermore, NSAIDs also aug-
mented IL-1b and IL-6 production from chondrocytes, after au-
tocrine stimulation with these cytokines. Based on these lines
of evidence, the mechanism of cartilage destruction by
NSAIDs is suggested to be as followed, (1) NSAIDs augment
IL-1b and IL-6 production from cytokine-activated chondro-
cytes; (2) theadditional IL-1band IL-6 induceMMPproduction;
and (3) the MMPs cause cartilage damage.
As shown in Table I, cytokines induced PGE2 production
from chondrocytes in the range 19e45 ng/mL; NSAIDs in-
hibited this PGE2 production by cytokines. This implies
that the inhibition of PGE2 by NSAIDs might cause induc-
tion of MMPs. To test this hypothesis, cells were incubated
with PGE2 and NSAIDs in the presence of cytokines. PGE2
production without cytokines was 20 ng/mL and that with
cytokine was 40 ng/mL. NSAID completely decreased cyto-
kine-induced PGE2 production, but not spontaneous pro-
duction in vitro study. In the rescue study, we added
10 ng/mL of PGE2. In this setting, MMP production was
never inﬂuenced. Therefore we concluded that PGE2 did
not inﬂuence MMP production. These results demonstrate
that the reduction of PGE2 by NSAIDs does not relate to
the augmentation of MMP production. However it remainsnecessary to investigate the mechanisms behind this phe-
nomenon in the future.
Loxoprofen was used as an NSAID in the rabbit experi-
ments, but it is a pro-drug and its active form is not commer-
cially available. Therefore, we used CLE and IND in this
study.We showed here that loxoprofen inducedMMPproduc-
tion in synovial lavage ﬂuid in the rabbit OA model in vivo and
bothCLE and IND augmented it in vitro.These results support
the notion that the augmentation ofMMPproduction is applied
to cyclooxygenase (COX) inhibitors in general.
IL-6þ sIL-6R-induced MMP-1, MMP-3 and MMP-13 pro-
duction in chondrocytes. In the preliminary study before,
we examined doseeresponse of IL-6þ sIL-6R on MMP pro-
ductions. From the result, we used the concentration (IL-6;
100 ng/mL, sIL-6R; 100 ng/mL) which indicated the maximal
response. This result is consistent with previous data re-
ported by Legendre et al.21. However, the present study is
the ﬁrst to show that HA inhibited IL-6þ sIL-6R-induced pro-
duction of MMPs and IL-6 in human chondrocytes and that
HA also inhibited NSAID-augmented production of MMPs
and cytokine production, although it has been previously re-
ported that it suppressed IL-1b-induced MMP production22.
Therefore, we suggest that the reduction of IL-1b and IL-6
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Fig. 4. HA inhibited the NSAID-induced augmentation of MMP and IL-6 production. Human chondrocytes were stimulated for 24 h with IL-
6/sIL-6R in the presence of an NSAID (1000 nM CEL or 100 nM IND) with and without HA. After culture, the concentrations of MMPs and IL-6
in the supernatant were determined by ELISA. ‘‘Control’’ indicates that only IL-6/sIL-6R was added. Columns and error bars indicate the mean
and SD of triplicate cultures. Statistical signiﬁcance was analyzed by Dunnett’s test (yP< 0.05 vs NSAIDþ IL-6/sIL-6R).
1517Osteoarthritis and Cartilage Vol. 17, No. 11by HA represents one mechanism for the inhibition of MMP
production and consequently cartilage destruction. However,
the molecular mechanisms whereby IL-1b, IL-6 and MMP
production is inhibited by HA remain undetermined. We are
currently investigating this issue further.15
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duced by IL-1b and IL-6 (Fig. 3). However, the inhibitory ef-
fect of HA on NSAID-accelerated MMP and cytokine
production was only partial (Figs. 4 and 5). These results
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1518 M. Hashizume and M. Mihara: Effect of HA and NSAID on MMP productioninduce MMP production and that these other pathways are
not inhibited by HA.
In conclusion, we ﬁnd that HA inhibited NSAID-acceler-
ated MMP production which was followed by inﬂammatory
cytokine production from cytokine-activated chondrocytes.
Clinical study is necessary to clarify the beneﬁt of the com-
binational therapy of HA and NSAIDs.
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